MCG Discovery Study in Emergency Departments

Last updated: October 17, 2025
Sponsor: SB Technology, Inc.
Overall Status: Completed

Phase

N/A

Condition

Heart Disease

Chest Pain

Angina

Treatment

Sponsor MCG device

Clinical Study ID

NCT06095557
SB-ACS-002
  • Ages > 18
  • All Genders

Study Summary

This prospective discovery study is designed to demonstrate the feasibility of using an unshielded, mobile MCG device in an Emergency Department (ED) setting. The main question it aims to answer is whether interpretable data can be reliably collected as part of an ED workflow.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Presents to ED with symptoms of Acute Coronary Syndrome (ACS)

  • Can provide written consent

Exclusion

Exclusion Criteria:

  • Presents to ED with ST-Elevation Myocardial Infarction (STEMI)

  • Presents to ED with Atrial Fibrillation

  • Clear non-ischemic cause for symptoms (i.e. trauma)

  • Active thoracic metal implants

Study Design

Total Participants: 124
Treatment Group(s): 1
Primary Treatment: Sponsor MCG device
Phase:
Study Start date:
October 30, 2023
Estimated Completion Date:
July 08, 2025

Connect with a study center

  • Icahn School of Medicine at Mount Sinai

    New York, New York 10029
    United States

    Site Not Available

  • Icahn School of Medicine at Mount Sinai

    New York 5128581, New York 5128638 10029
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.